thecronosgroup.com (CRON): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Graphic logo of thecronosgroup.com (CRON)

Does the support of a major tobacco partner help Cronos Group Inc. (CRON) maintain resilience? Despite tax pressures and uncertainty regarding legalization in the US, Cronos Group Inc. (CRON) minimizes risks through global expansion and scientific research. The EV/EBITDA multiple trend visualizes the market reaction to news, while the 22.16 indicator reflects the status of the current business valuation relative to its operating profit.

CRON Cronos Group Inc: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/11/2026

Comprehensive metric breakdowns and analytics for thecronosgroup.com (CRON)

- current price and projected stock value:
Stock Price Cronos|CRON - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value Cronos Corp|CRON - Value Adjusted for Debt and Cash
- book value of equity indicators:
Net Assets per Single Share Cronos Group|CRON - Company Net Assets|Market Capitalization to Book Value Ratio thecronosgroup.com|CRON - Cumulative Company Assets
- debt and solvency information:
Debt to Equity Cronos Group Inc.|CRON - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cronos Group|CRON - Company Cumulative Debt|Debt to Book Capitalization Ratio Cronos Corp|CRON - Company Long-Term Indebtedness|Company Short-Term Debt Cronos Group|Quick Liquidity thecronosgroup.com
- business earnings and investment ratios data:
CRON - Net Financial Result|Future Profit Cronos Group Inc.|CRON - Company Value to Net Income|Forward P/E Multiple Cronos Group Inc.|CRON - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cronos Corp|CRON - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Cronos Group|CRON - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months thecronosgroup.com|CRON - Earnings growth in current year|Net earnings per share growth forecast for next year Cronos Group Inc.
Initial company analysis:CRON (Cronos)
Original product of Cronos Group

To identify undervalued assets, an investor must compare the enterprise value, including debt and taxes, against operating profit before depreciation and amortization. This calculation filters out market noise and evaluates the efficiency of the Cronos Group Inc. (CRON) model, where cultivation outsourcing reduces capital expenditures, a trend clearly reflected in the EV/EBITDA valuation dynamics, which helps determine the company's fair value.

Competitor analysis for Cronos Group Inc.

EV/EBITDA Multiple INDV (Indivior Group)|EV/EBITDA Multiple Collegium Corp COLL|CGC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation HITI (hightideinc.com)|auroramj.com (ACB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Achieve Life Sciences Inc.|SKYE (Skye Bioscience, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Anebulo Pharma (ANEB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InterCure Ltd. (INCR)|NTRB (nutriband.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nasus Pharma NSRX|India Globalization Capital (IGC) - Company Value to EBITDA|MIRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|FLGC (Flora Growth Inc) - Enterprise Value to Operating Income Before Depreciation|imcannabis.com (IMCC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Adial Pharmaceuticals, Inc. (ADIL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artelo Biosciences Inc.|Ensysce (ENSC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TTNP (Titan Pharmaceuticals)|GNLN (Greenlane Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple INM (InMed Pharmaceuticals)|Enterprise Value to EBITDA Multiple akandacorp.com|ENVB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation BGXX (Bright Green)|Hempacco (HPCO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization